To investigate RSV's efficacy in CRC prevention and treatment, researchers employed a genetically engineered mouse model in which APC was knocked out and Kras was specifically activated in the distal colon, simulating sporadic CRC (43). This evidence concerns the gene KRAS and colorectal carcinoma.